イスラエルで最高の化学療法医師 - トップ21名の医師

ペレス・シャロン医師は、ソウラスキー医療センターにおいて、腹腔内温熱化学療法（HIPEC）を含む高度な化学療法技術を専門としています。

• 各種がんに対する免疫療法および分子標的療法の専門家
• 臨床試験に対する患者の意識に関する臨床研究を実施
• 膵頭十二指腸切除術（ウィップル手術）および肝切除術などの複雑な外科手術を施行
• がんの種類に応じた複数の化学療法アプローチを提供

ソウラスキー医療センターにおいて、肉腫および整形外科腫瘍学の分野で豊富な研究・臨床経験を持つ第一人者。

• 2000年より軟部組織・骨腫瘍科科長
• パリのギュスターヴ・ルシー研究所にてフェローシップ研修修了
• ESMO肉腫グループファカルティメンバー
• 腫瘍免疫学研究における先駆的業績
• イスラエル腫瘍放射線治療学会元会長

Dr. David Sarid is a specialist in oncology and radiotherapy based in Israel with expertise in chemotherapy, radiotherapy, and biological cancer therapy. He has been educated in the UK, Israel, and Georgia and has written over 30 articles devoted to cancer treatment. He is a lecturer at Tel Aviv University and a member of several medical organizations.

スーラスキー医療センター腫瘍内科部長 – ウォルフ医師は高度な化学療法治療を専門としています。

• 腫瘍内科および一般内科における豊富な経験
• ネゲブ・ベングリオン大学卒業
• 陸軍医療部隊での勤務経験あり
• 国際患者への対応のため英語に堪能

アリ・ラファエル教授――テルアビブ・スラスキー医療センター（イキロフ、テルアビブ）トランスレーショナル腫瘍学部門長および臨床がん研究部門研究員。患者一人ひとりのニーズに寄り添う個別対応のアプローチが高く評価されています。

資格および患者への貢献：

• 腫瘍科デイホスピタルを統括し、国家ゲノム医療プロジェクトを主導。最先端の研究へのアクセスを提供しています。

• 主任副研究者および主任研究者として、腫瘍内mRNA投与やウイルス製剤を含むフェーズI〜IIIの多数の臨床試験に携わってきました。患者は革新的な治療法への参加機会を得られます。

• 米国および英国における国際的な臨床経験を有し、世界水準の治療基準と先進的なプロトコルの適用を保証しています。

• 国際学術団体の会員（ESMO、IASLC、ISLB、ISCORT、Israeli Medical Association）。最新の治療基準を活用し、国際的な研究に参画しています。

• 　ICH GCP R2、Israeli MOH Guidelinesをはじめ、インフォームドコンセント、副作用管理および患者安全に関する最新課程を含む国際臨床実践基準に基づき、定期的に専門知識の更新および研修を実施しています。

ラファエル教授は、精密な治療レジメンの選択、革新的手法の導入、そして細やかな患者対応により高い信頼を得ており、治療のすべての段階において患者が安心して療養に臨める環境を提供しています。

Dr. Michael Shapira is a specialist in Bone Marrow Transplantation with over 20 years of experience. He graduated from the Hebrew University Medical School in 1999. He completed his training in internal medicine at Hadassah Medical Center.

Dr. Shapira is a senior physician in the Bone Marrow Transplantation department at Hadassah. He has played a key role in many successful transplants and has helped maintain high patient survival rates. He is known for his clinical skills and commitment to improving transplantation medicine.

Dr. Dror Levin is a senior pediatrician and director of the blood disorder and bone cancer (sarcoma) treatment departments at Children's Hospital "Dana" and Medical Center "Sourasky" respectively. He is a specialist in pediatric medicine, hematology, and oncology, with additional experience studying abroad at the Rizzoli Orthopaedic Institute in Italy.

Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.

Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.

Prof. Peled is a leading specialist in lung cancer immunotherapy, with expertise in Internal Medicine, Pulmonology and Medical Oncology. He has received the ASCO Merit Award, and is the head of the Thoracic Cancer Unit at Davidoff Cancer Center and Head of the Research and Detection Unit for Thoracic malignancies at Sheba Medical Center. He is a member of the Thoracic Oncology Assembly of the European Respiratory Society and Chair of the Early Detection and Prevention Committee of the International Association for the Study of Lung Cancer.

Chief Physician of the Oncology Center, Oncologist

Oncologist, Radiologist

Oncohematologist

Dr. Tamar Jablonski-Perec is an oncologist at Hadassah Medical Center in Jerusalem. She holds a Doctor of Medical Sciences from the Hebrew University and has experience from the renowned Sloan-Kettering Cancer Center in New York. She is the Head of Institute of Oncology, Head of Breast Cancer Treatment Center, and Professor of the Department of Oncology at the Hebrew University. She is a member of several international cancer communities and was awarded a scholarship from the Hadassah Medical School.

Radiotherapy specialist, Oncologist

Children's Oncologist

Head of the Department of Pediatric Hematology and Oncology.

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.